ArticlebioRxiv : the preprint server for biology2023

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.

Nicolas Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.